NSHM Knowledge Campus, Kolkata Group of Institutions, 124 BL Saha Road, Kolkata 700053, West Bengal, India.
NSHM Knowledge Campus, Kolkata Group of Institutions, 124 BL Saha Road, Kolkata 700053, West Bengal, India.
Int J Biol Macromol. 2019 Jun 1;130:34-49. doi: 10.1016/j.ijbiomac.2019.02.094. Epub 2019 Feb 16.
Oral chemotherapy is the most preferred drug administration method due to non-invasive administration, more convenient, low healthcare cost, and patient compliance in comparison to intravenous chemotherapy. However, oral chemotherapy poses numerous hurdles to drug absorption through the gastrointestinal tract. Recently, nanocarriers have been extensively used for delivering anticancer drugs orally. Nanocarriers present distinctive advantages that comprise aiding drug dissolution owing to high surface to volume ratio, surface modifiability, protecting drugs from the harsh gastrointestinal environments and other features, all of which contribute to enhanced drugs bioavailability. Nanocarriers based on polysaccharides have emerged as the favored choice owing to their low/non-toxicity, biodegradability, and biocompatibility. In the last decade, the research on oral delivery of anticancer drug using polysaccharide nanocarrier has diversified in many fields. Yet there is no report that summaries these advances. This article aims to bridge that lacuna. In this review article, we have discussed the problems associated with oral chemotherapy and conquer these through polysaccharide nanocarriers. This review also provides a general idea on the current developments in polysaccharide nanocarrier for oral bioavailability enhancement of anticancer drugs.
口服化疗因其非侵入性给药、更方便、医疗保健成本低以及患者依从性优于静脉化疗,是最受青睐的药物给药方法。然而,口服化疗在胃肠道吸收方面存在诸多障碍。最近,纳米载体被广泛用于口服递抗癌药物。纳米载体具有独特的优势,包括由于高表面积与体积比、表面可修饰性、保护药物免受恶劣胃肠道环境等特性,有助于提高药物的生物利用度。基于多糖的纳米载体因其低/无毒、可生物降解和生物相容性而成为首选。在过去的十年中,使用多糖纳米载体的抗癌药物口服递的研究在许多领域都有了多样化的发展。然而,目前还没有关于这些进展的综述报道。本文旨在填补这一空白。在这篇综述文章中,我们讨论了与口服化疗相关的问题,并通过多糖纳米载体克服了这些问题。本文还概述了多糖纳米载体在提高抗癌药物口服生物利用度方面的最新进展。